123
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Development of 400 µm Pellets by Extrusion‐Spheronization Application with Gelucire 50/02 to Produce a “Sprinkle” Form

, , , &
Pages 43-51 | Published online: 02 Feb 2004

References

  • Gayot A., Lafaille P., Leterme P., Baume B., Traisnel M. Essais de fabrication de granules et globules inertes à usage homéopathique par extrusion ou extrusion—découpe et sphéronisation. STP Pharma 1985; 1(3)189–193
  • Mouton R., Gayot A. Evaluation de l'influence des conditions opératoires d'un extrudeur à cylindres et d'un sphéroniseur. STP Pharma 1988; 4(8)648–655
  • Gayot A., Leterme P. La technique d'extrusion‐sphéronisation. Acta Technol. Legis Medicam. 1990; 1(2)81–100
  • Newton J. M. The preparation of spherical granules by extrusion/spheronization. STP Pharma 1990; 6(6)396–398
  • Follonier N., Doelker E. Biopharmaceutical comparison of oral multiple unit and single unit sustained release dosage form. STP Pharma Sci. 1992; 2(2)141–158
  • Newton J. M., Chow A. K., Jeewa K. B. The effect of excipient source on spherical granules made by extrusion/spheronization. Pharm. Technol. Int. October, 1992; 52–58
  • Newton J. M., Chapman J. R., Rowe R. C. The influence of process variables on the preparation and properties of spherical granules by the process of extrusion and spheronization. Int. J. Pharm. 1995; 120: 101–109
  • Raines C. L., Newton J. M. The extrusion rheology of various grades of microcrystalline cellulose. J. Pharm. Pharmacol. 1987; 39: 90
  • Kjellman N. I.M., Croner S., Leijon I., Friber G. K., Thuresson S. O. Theophylline pharmacokinetics in children, comparing sustained release spheres (Theo‐Dur sprinkle) with elixir. Eur. J. Pediatr. 1988; 148: 278–280
  • Carrigan P. J., Bunker D. R., Cavanaugh J. H., Lamm J. E., Cloyd J. C. Absorption characteristics of a new valproate formulation: divalproex sodium‐coated particles in capsules/Depakote sprinkle. J. Clin. Pharmacol. 1990; 30(8)743–747
  • Malinowski H. J., Smith W. E. Use of factorial design to evaluate granulations prepared by spheronization. J. Pharm. Sci. October, 1975; 64(10)1688–1692
  • Hileman G. A., Goskonda S. R., Spalitto A., Upadrashta S. M. A factorial approach to high dose product development by an extrusion‐spheronization process. Drug Dev. Ind. Pharm. 1993; 19(4)483–491
  • Harrison P. J., Newton J. M., Rowe R. C. The characterisation of wet powder masses suitable for extrusion/spheronization. J. Pharm. Pharmacol. 1985a; 37: 686–691
  • Harrison P. J., Newton J. M., Rowe R. C. The application of capillary rheometry to the extrusion of wet powder masses. Int. J. Pharm. 1987; 35: 235–242
  • Bianchini R., Vecchio C. Oral controlled release optimization of pellets prepared by extrusion‐spheronization processing. II. Pharmaco 1989; 44(6)645–654
  • Pinto J. F., Buckton G., Newton J. M. The influence of four selected processing and formulation factors on the production of spheres by extrusion and spheronization. Int. J. Pharm. 1992; 83: 187–196
  • Goodhart F., Ronald Draper J., Ninger F. C. Design and use of a laboratory extruder for pharmaceutical granulations. J. Pharm. Sci. January, 1973; 62(1)133–136
  • Chapman S. R., Rowe R. C., Harrison P. J., Newton J. M. The influence of process variables on the density of granules produced by extrusion‐spheronization. 4e Congrès Int. Technol. Pharm. APGI Paris June, 1986; 9–14
  • Benbow J. J., Oxley E. W., Bridgwater J. The extrusion mechanics of pastes. The influence of paste formulation on extrusion parameters. Chem. Eng. Sci. 1987; 42(9)2151–2162
  • Vervaet C., Baert L., Risha P., Remon J. P. The influence of the extrusion screen on pellet quality using an instrumented basket extruder. Int. J. Pharm. 1994; 107: 29–39
  • Harrison P. J., Newton J. M., Rowe R. C. Flow defects in wet powder mass extrusion. J. Pharm. Pharmacol. 1985b; 37: 81–83
  • Dietrich R. Food technology transfers to pellet production. Manuf. Chem. August, 1989; 30–33
  • Dupont G., Flament M. P., Leterme P., Farah N., Gayot A. Developing of a study method for producing 400 µm spheroids. Int. J. Pharm. 2002; 247: 159–165

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.